New & Notable
Skin substitute spending driven by patients, products, prices
A new analysis shows continued growth in Medicare's skin substitute spending, driven by higher prices, more patients and greater product use.
Health system CEOs in hot seat over their role in raising healthcare prices
During a high-profile congressional hearing on Tuesday, one lawmaker said hospitals charge “an insane amount” for care. Still, the CEOs largely passed the buck, arguing their prices are justified.
— Healthcare Dive
AMA alerts officials of health plans' No Surprises Act abuse
More than 100 provider groups call for greater enforcement of the No Surprises Act after accusing health plans of circumventing its intent and raising patient costs.
Prices rose after No Surprises arbitration for some care: analysis
The data, compiled by the Brookings Center on Health Policy, shows that average prices for some services like imaging were seven-times higher than Medicare prices.
— Healthcare DiveSponsored Sites
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
Skin substitute spending driven by patients, products, prices
A new analysis shows continued growth in Medicare's skin substitute spending, driven by higher prices, more patients and greater product use.
-
AMA alerts officials of health plans' No Surprises Act abuse
More than 100 provider groups call for greater enforcement of the No Surprises Act after accusing health plans of circumventing its intent and raising patient costs.
-
When brand-name drugs need a prior auth, brace for delays
A study uncovered friction at the pharmacy, revealing days-long delays and frequent denials when brand-name prescription drugs need a prior authorization.
-
Before revenue cycle AI, payers and providers need to get along
A survey shows that most providers say disagreements with payers over claims prevent timely and full reimbursement.
-
AI arms race leading to prior auth problems, reimbursement cuts
Early adoption of AI for prior authorizations and medical billing is inflating medical spending, prompting payers to slash reimbursement rates.
-
Judge dismisses No Surprises Act lawsuit against HaloMD
A California federal court threw out Elevance Health's lawsuit against HaloMD, alleging the organization has gamed the No Surprises Act's IDR process for profit.
Features
-
The U.S. finally bent the healthcare cost curve, one economist says
Health economist David Cutler's new analysis shows a deceleration in U.S. healthcare spending as technology advancements make care cheaper.
-
How AI scribes are shifting coding intensity, reimbursement
The proliferation of AI scribes for clinical documentation has started a shift in coding intensity, raising concerns about reimbursement and affordability.
-
Agentic AI evolution begins to pave way for autonomous revenue cycle
A fully automated revenue cycle in which staff work hand-in-hand with AI is looming, but success will require a mature AI strategy.
-
How NGHS balances revenue cycle AI adoption, ROI
Northeast Georgia Health System is accelerating AI adoption, especially in revenue cycle management, but leaders have learned to balance speed of innovation with ongoing ROI.